Taken together, these results reveal that PTPROt aggravates inflammation via two ways, the NF-κB-induced transcription and the NF-κB-ROS-inflammasome-proinflammatory cytokine axis, in liver macrophages during NASH. This evidence concerns the gene PTPRO and metabolic dysfunction-associated steatohepatitis.